Publication Name	World Journal of Pharmacology
Manuscript ID	13999
Country	United States

Received	2014-09-12 08:15
Peer-Review Started	2014-09-13 18:47
To Make the First Decision	2014-11-14 18:51
Return for Revision	2014-11-19 16:59
Revised	2014-12-22 00:00
Second Decision	2015-02-26 17:15
Accepted by Journal Editor-in-Chief	2015-02-27 18:43
Accepted by Company Editor-in-Chief	2015-03-05 09:11
Articles in Press	2015-03-05 09:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-06-01 16:00
Publish the Manuscript Online	2015-06-19 15:32

ISSN	2220-3192 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pediatrics
Manuscript Type	Review
Article Title	Lipoprotein based drug delivery: Potential for pediatric cancer applications
Manuscript Source	Invited Manuscript
All Author List	Nirupama Sabnis, W Paul Bowman and Andras G Lacko
Funding Agency and Grant Number
Corresponding Author	Andras G Lacko, PhD, Department of Pediatrics, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, United States. andras.lacko@unthsc.edu
Key Words	Drug delivery; Lipoprotein; Nanoparticles; Pediatric cancers; High density lipoprotein
Core Tip	While survival rates for patients with childhood cancers have improved, the quality of life of survivors is often adversely impacted by the residual effects of therapy. Consequently, new approaches will be required to increase the efficacy and to minimize the drug related toxic side effects of pediatric cancer therapy. Nanotechnology is a potentially effective tool to improve cancer chemotherapy via enhanced bioavailability and specific targeting. Lipoprotein based formulations have shown particularly strong promise to improve cancer therapeutics. The present article describes the challenges faced in the treatment of pediatric cancers and reviews the potential of lipoprotein-based therapeutics for these malignancies.
Publish Date	2015-06-19 15:32
Citation	Sabnis N, Bowman WP, Lacko AG. Lipoprotein based drug delivery: Potential for pediatric cancer applications. World J Pharmacol 2015; 4(2): 172-179
URL	http://www.wjgnet.com/2220-3192/full/v4/i2/172.htm
DOI	http://dx.doi.org/10.5497/wjp.v4.i2.172

Full Article (PDF)	WJP-4-172.pdf
Full Article (Word)	WJP-4-172.doc
Manuscript File	13999-Review.docx
Answering Reviewers	13999-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13999-Conflict-of-interest statement .pdf
Copyright License Agreement	13999-Copyright assignment.pdf
Peer-review Report	13999-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	13999-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	13999-Scientific misconduct check.pdf
Scientific Editor Work List	13999-Scientific editor work list.pdf